Antikor attending the inaugural Novel Format Conjugates Summit April 2022

Dr Deonarain will be attending the inaugural Novel Format Conjugates Summit and presenting new data on Antikor Biopharma's latest programs, 25-27 April, Boston, USA.

Antikor will present a poster called ‘Gastric Cancer Antibody FDCs’ at AACR April 2022

Dr Yahioglu (in person) and Dr Deonarain (virtual) are attending the AACR Annual Aeeting 8-13 April, 2022, New Orleans, USA and will present a poster called (Abstract Number: 5327): Gastric cancer antibody fragment drug-conjugates (FDCs): Succeeding in solid tumors where ADCs fail.

Antikor presenting a poster at the World ADC London Conference March/April 2022

Antikor will be attending and presenting a poster at the World ADC London Conference, 29 March-1 April, London.

Antikor is presenting the Stream Keynote Lecture ‘Advances in ADC Engineering’ at Biologics UK 2022

Dr M Deonarain is attending and giving the Stream Keynote Lecture “Advances in ADC Engineering” at Oxford Global's Biologics UK Conference on 21-22 March, 2022, London.

Antikor presenting at the 6th Annual Next-Generation Immuno-oncology Conference, March 2022

Dr Deonarain is attending and presenting a lecture titled "Development of Next-Generation Antibody Fragment Drug Conjugates Tailored for Gastric Cancer" at the 6th Annual Next-Generation Immuno-oncology Conference, 10-11 March, 2022, London.